Literature DB >> 26317848

The L3MBTL3 Methyl-Lysine Reader Domain Functions As a Dimer.

Brandi M Baughman1, Samantha G Pattenden1, Jacqueline L Norris1, Lindsey I James1, Stephen V Frye1.   

Abstract

L3MBTL3 recognizes mono- and dimethylated lysine residues on histone tails. The recently reported X-ray cocrystal structures of the chemical probe UNC1215 and inhibitor UNC2533 bound to the methyl-lysine reading MBT domains of L3MBTL3 demonstrate a unique and flexible 2:2 dimer mode of recognition. In this study, we describe our in vitro analysis of L3MBTL3 dimerization via its MBT domains and additionally show that this dimerization occurs within a cellular context in the absence of small molecule ligands. Furthermore, mutations to the first and second MBT domains abrogated L3MBTL3 dimerization both in vitro and in cells. These observations are consistent with the hypothesis that L3MBTL3 engages methylated histone tails as a dimer while carrying out its normal function and provides an explanation for the presence of repeated MBT domains within L3MBTL3.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26317848      PMCID: PMC4775453          DOI: 10.1021/acschembio.5b00632

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  35 in total

Review 1.  Polycomb silencing mechanisms and the management of genomic programmes.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

2.  Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins.

Authors:  Tim J Wigle; J Martin Herold; Guillermo A Senisterra; Masoud Vedadi; Dmitri B Kireev; Cheryl H Arrowsmith; Stephen V Frye; William P Janzen
Journal:  J Biomol Screen       Date:  2009-12-11

3.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

4.  Structural basis for the methylation state-specific recognition of histone H4-K20 by 53BP1 and Crb2 in DNA repair.

Authors:  Maria Victoria Botuyan; Joseph Lee; Irene M Ward; Ja-Eun Kim; James R Thompson; Junjie Chen; Georges Mer
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

5.  Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

Authors:  Minjia Tan; Hao Luo; Sangkyu Lee; Fulai Jin; Jeong Soo Yang; Emilie Montellier; Thierry Buchou; Zhongyi Cheng; Sophie Rousseaux; Nisha Rajagopal; Zhike Lu; Zhen Ye; Qin Zhu; Joanna Wysocka; Yang Ye; Saadi Khochbin; Bing Ren; Yingming Zhao
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

6.  Relationship between histone H3 lysine 9 methylation, transcription repression, and heterochromatin protein 1 recruitment.

Authors:  M David Stewart; Jiwen Li; Jiemin Wong
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

7.  The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.

Authors:  Michelle A Camerino; Nan Zhong; Aiping Dong; Bradley M Dickson; Lindsey I James; Brandi M Baughman; Jacqueline L Norris; Dmitri B Kireev; William P Janzen; Cheryl H Arrowsmith; Stephen V Frye
Journal:  Medchemcomm       Date:  2013-11       Impact factor: 3.597

Review 8.  Targeting chromatin readers.

Authors:  L I James; S V Frye
Journal:  Clin Pharmacol Ther       Date:  2013-01-17       Impact factor: 6.875

9.  Histone recognition by human malignant brain tumor domains.

Authors:  Nataliya Nady; Liubov Krichevsky; Nan Zhong; Shili Duan; Wolfram Tempel; Maria F Amaya; Mani Ravichandran; Cheryl H Arrowsmith
Journal:  J Mol Biol       Date:  2012-09-04       Impact factor: 5.469

10.  Drug discovery toward antagonists of methyl-lysine binding proteins.

Authors:  J Martin Herold; Lindsey A Ingerman; Cen Gao; Stephen V Frye
Journal:  Curr Chem Genomics       Date:  2011-08-22
View more
  5 in total

Review 1.  Chemical modulators for epigenome reader domains as emerging epigenetic therapies for cancer and inflammation.

Authors:  Nilesh Zaware; Ming-Ming Zhou
Journal:  Curr Opin Chem Biol       Date:  2017-07-06       Impact factor: 8.822

Review 2.  Chemical probes for methyl lysine reader domains.

Authors:  Lindsey I James; Stephen V Frye
Journal:  Curr Opin Chem Biol       Date:  2016-06-25       Impact factor: 8.822

3.  Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.

Authors:  Luca A Lotta; Pawan Gulati; Felix R Day; Felicity Payne; Halit Ongen; Martijn van de Bunt; Kyle J Gaulton; John D Eicher; Stephen J Sharp; Jian'an Luan; Emanuella De Lucia Rolfe; Isobel D Stewart; Eleanor Wheeler; Sara M Willems; Claire Adams; Hanieh Yaghootkar; Nita G Forouhi; Kay-Tee Khaw; Andrew D Johnson; Robert K Semple; Timothy Frayling; John R B Perry; Emmanouil Dermitzakis; Mark I McCarthy; Inês Barroso; Nicholas J Wareham; David B Savage; Claudia Langenberg; Stephen O'Rahilly; Robert A Scott
Journal:  Nat Genet       Date:  2016-11-14       Impact factor: 38.330

Review 4.  Chemical genetics approaches for selective intervention in epigenetics.

Authors:  Andrew C Runcie; Kwok-Ho Chan; Michael Zengerle; Alessio Ciulli
Journal:  Curr Opin Chem Biol       Date:  2016-07-14       Impact factor: 8.822

5.  Gene expression profiling of upregulated mRNAs in granulosa cells of bovine ovulatory follicles following stimulation with hCG.

Authors:  Jacques G Lussier; Mame N Diouf; Valérie Lévesque; Jean Sirois; Kalidou Ndiaye
Journal:  Reprod Biol Endocrinol       Date:  2017-11-03       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.